Aprinoia Therapeutics Inc.   Report issue

For profit Phase 2
Founded: Taipei City Taiwan (2015)

Organization Overview

First Clinical Trial
2019
NCT04141150
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

APRINOIA Therapeutics | Aprinoia Therapeutics Inc. | APRINOIA Therapeutics, LLC